EP3670649A4 - Method for culturing 3-dimensional lung cancer organoid and method for preparing patient-derived xenograft animal model using same - Google Patents
Method for culturing 3-dimensional lung cancer organoid and method for preparing patient-derived xenograft animal model using same Download PDFInfo
- Publication number
- EP3670649A4 EP3670649A4 EP18845684.2A EP18845684A EP3670649A4 EP 3670649 A4 EP3670649 A4 EP 3670649A4 EP 18845684 A EP18845684 A EP 18845684A EP 3670649 A4 EP3670649 A4 EP 3670649A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- culturing
- lung cancer
- same
- animal model
- derived xenograft
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 title 1
- 238000010171 animal model Methods 0.000 title 1
- 238000012258 culturing Methods 0.000 title 1
- 201000005202 lung cancer Diseases 0.000 title 1
- 208000020816 lung neoplasm Diseases 0.000 title 1
- 210000002220 organoid Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0688—Cells from the lungs or the respiratory tract
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/12—Animals modified by administration of exogenous cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0331—Animal model for proliferative diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0393—Animal model comprising a reporter system for screening tests
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/113—Acidic fibroblast growth factor (aFGF, FGF-1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2513/00—3D culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Environmental Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170103121A KR102152492B1 (en) | 2017-08-14 | 2017-08-14 | Method for culturing 3D lung cancer organoid and preparing patient-derived xenograft model using thereof |
PCT/KR2018/009254 WO2019035618A1 (en) | 2017-08-14 | 2018-08-13 | Method for culturing 3-dimensional lung cancer organoid and method for preparing patient-derived xenograft animal model using same |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3670649A1 EP3670649A1 (en) | 2020-06-24 |
EP3670649A4 true EP3670649A4 (en) | 2021-10-13 |
Family
ID=65361981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18845684.2A Pending EP3670649A4 (en) | 2017-08-14 | 2018-08-13 | Method for culturing 3-dimensional lung cancer organoid and method for preparing patient-derived xenograft animal model using same |
Country Status (4)
Country | Link |
---|---|
US (2) | US11883508B2 (en) |
EP (1) | EP3670649A4 (en) |
KR (1) | KR102152492B1 (en) |
WO (1) | WO2019035618A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102324038B1 (en) * | 2019-07-24 | 2021-11-10 | 덕성여자대학교 산학협력단 | Colorectal Cancer Xenograft Animal Model using Cancer Organoid And Endothelial Colony Forming Cells And Manufacturing Method Thereof |
CN112080472B (en) * | 2020-09-01 | 2022-05-31 | 南通大学 | Method for culturing human lung cancer organoid 3D model special for biomedical function research |
CN112501110B (en) * | 2020-11-26 | 2023-08-25 | 海西纺织新材料工业技术晋江研究院 | Standardized culture medium for three-dimensional culture of lung and lung cancer tissue organoids and culture method |
KR20220117170A (en) * | 2021-02-16 | 2022-08-23 | 연세대학교 산학협력단 | High purity cancer organoids and a method of producing thereof |
KR102652944B1 (en) * | 2021-04-14 | 2024-03-29 | 연세대학교 산학협력단 | A method for maintaining structure of fibrosis-encapsulated tumoroid |
CN114736867A (en) * | 2022-03-23 | 2022-07-12 | 盐城市第一人民医院 | Lung and lung cancer tissue culture method and method for constructing lung cancer mouse animal model by using same |
CN114606192B (en) * | 2022-03-30 | 2023-08-08 | 南方医科大学南方医院 | Kras/Lkb1 mutant non-small cell lung cancer organoid culture solution and culture method |
KR20230151722A (en) | 2022-04-26 | 2023-11-02 | 재단법인 아산사회복지재단 | Method for preparing organoids using three-dimensional culture of cells |
KR20240002172A (en) | 2022-06-28 | 2024-01-04 | 가톨릭대학교 산학협력단 | Lung cancer modeling using normal alveolar organoids with lung cancer cells |
CN115261302B (en) * | 2022-07-20 | 2023-06-06 | 创芯国际生物科技(广州)有限公司 | Matrigel and preparation method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016083613A2 (en) * | 2014-11-27 | 2016-06-02 | Koninklijke Nederlandse Akademie Van Wetenschappen | Culture medium |
WO2016093359A1 (en) * | 2014-12-11 | 2016-06-16 | 学校法人慶應義塾 | Method for producing therapeutic corneal endothelial substitute cell sphere |
US20210147810A1 (en) * | 2017-06-28 | 2021-05-20 | Rutgers, The State University Of New Jersey | Single lung cell-derived organoids |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101674468B1 (en) * | 2013-05-07 | 2016-11-10 | 재단법인 아산사회복지재단 | Methods for cultivation of patient derived primary cultured turmor cell (PCC) and patient-derived tumor xenograft (PDX) animal model produced by using PCC |
US20170267977A1 (en) | 2014-07-30 | 2017-09-21 | University Health Network | Organoids for drug screening and personalized medicine |
AU2016205284B2 (en) * | 2015-01-07 | 2021-09-09 | Dana-Farber Cancer Institute, Inc. | Microfluidic cell culture of patient-derived tumor cell spheroids |
US20170285002A1 (en) * | 2016-03-16 | 2017-10-05 | Public University Corporation Yokohama City University | Method for reconstituting tumor with microenvironment |
-
2017
- 2017-08-14 KR KR1020170103121A patent/KR102152492B1/en active IP Right Grant
-
2018
- 2018-08-13 US US16/638,801 patent/US11883508B2/en active Active
- 2018-08-13 WO PCT/KR2018/009254 patent/WO2019035618A1/en unknown
- 2018-08-13 EP EP18845684.2A patent/EP3670649A4/en active Pending
-
2023
- 2023-12-08 US US18/533,611 patent/US20240108762A1/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016083613A2 (en) * | 2014-11-27 | 2016-06-02 | Koninklijke Nederlandse Akademie Van Wetenschappen | Culture medium |
WO2016093359A1 (en) * | 2014-12-11 | 2016-06-16 | 学校法人慶應義塾 | Method for producing therapeutic corneal endothelial substitute cell sphere |
US20210147810A1 (en) * | 2017-06-28 | 2021-05-20 | Rutgers, The State University Of New Jersey | Single lung cell-derived organoids |
Non-Patent Citations (6)
Title |
---|
"Current Protocols in Pharmacology", 1 March 2013, JOHN WILEY & SONS, INC., Hoboken, NJ, USA, ISBN: 978-0-471-14175-4, article YOKO S. DEROSE ET AL: "Patient-Derived Models of Human Breast Cancer: Protocols for In Vitro and In Vivo Applications in Tumor Biology and Translational Medicine", XP055576552, DOI: 10.1002/0471141755.ph1423s60 * |
CHRISTINA E. BARKAUSKAS ET AL: "Lung organoids: current uses and future promise", DEVELOPMENT, vol. 144, no. 6, 14 March 2017 (2017-03-14), GB, pages 986 - 997, XP055576557, ISSN: 0950-1991, DOI: 10.1242/dev.140103 * |
DUTTA DEVANJALI ET AL: "Disease Modeling in Stem Cell-Derived 3D Organoid Systems", TRENDS IN MOLECULAR MEDICINE, vol. 23, no. 5, 1 May 2017 (2017-05-01), GB, pages 393 - 410, XP055835916, ISSN: 1471-4914, DOI: 10.1016/j.molmed.2017.02.007 * |
HUO KU-GENG ET AL: "Patient-derived cell line, xenograft and organoid models in lung cancer therapy", TRANSLATIONAL LUNG CANCER RESEARCH, vol. 9, no. 5, 1 October 2020 (2020-10-01), pages 2214 - 2232, XP055835907, ISSN: 2218-6751, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653147/pdf/tlcr-09-05-2214.pdf> DOI: 10.21037/tlcr-20-154 * |
ILIE MARIUS ET AL: "Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps", CANCER MEDICINE, vol. 4, no. 2, 1 February 2015 (2015-02-01), GB, pages 201 - 211, XP055836076, ISSN: 2045-7634, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329004/pdf/cam40004-0201.pdf> DOI: 10.1002/cam4.357 * |
KIM MINSUH ET AL: "Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening", NATURE COMMUNICATIONS, vol. 10, no. 1, 1 December 2019 (2019-12-01), XP055823158, Retrieved from the Internet <URL:https://www.nature.com/articles/s41467-019-11867-6.pdf> DOI: 10.1038/s41467-019-11867-6 * |
Also Published As
Publication number | Publication date |
---|---|
US20210128752A1 (en) | 2021-05-06 |
EP3670649A1 (en) | 2020-06-24 |
US20240108762A1 (en) | 2024-04-04 |
KR20190018306A (en) | 2019-02-22 |
KR102152492B1 (en) | 2020-09-04 |
WO2019035618A1 (en) | 2019-02-21 |
US11883508B2 (en) | 2024-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3670649A4 (en) | Method for culturing 3-dimensional lung cancer organoid and method for preparing patient-derived xenograft animal model using same | |
EP3811897A4 (en) | Three-dimensional oral model analysis method and prosthesis design method including same | |
EP3514228A4 (en) | Artificial tissue precursor and preparation method therefor | |
EP3652186A4 (en) | General and direct method for preparing oligonucleotide-functionalized metal-organic framework nanoparticles | |
EP3489262A4 (en) | Bispecific proteins and methods for preparing same | |
MX2016014066A (en) | Multiplex gene editing in swine. | |
EP3158535A4 (en) | 3d face model reconstruction apparatus and method | |
EP3464560A4 (en) | Compositions and methods for tumor vaccination and immunotherapy involving her2/neu | |
EP3385917A4 (en) | Method and apparatus for generating three-dimensional model using volumetric closest point approach method | |
EP3313976A4 (en) | Tissue culture apparatus and method | |
EP3272724A4 (en) | Powder material for three-dimensional modeling, three-dimensional modeling material set, method for producing three-dimensional model, apparatus for producing three-dimensional model, and three-dimensional model | |
EP3385333A4 (en) | Water-disintegrable resin composition, and three-dimensional modeling material set and method for producing three-dimensional model using same | |
EP3699275A4 (en) | Organ organoid and method for producing same | |
EP3533867A4 (en) | Human antibody producing non-human animal and method for preparing human antibodies using same | |
EP3120872A4 (en) | Dual-purpose pat/ultrasound contrast agent bound with nanoparticles containing drug and method for preparing same | |
EP3561059A4 (en) | Composition for base editing for animal embryo and base editing method | |
EP3375598A4 (en) | Three-dimensional modeling material set, method for producing three-dimensional model, and device for producing three-dimensional model | |
EP3295895A4 (en) | Combined model scanning and oral cavity scanning apparatus | |
EP3766965A4 (en) | Method for preparing 3d brain organ | |
EP3860575A4 (en) | Method for preparing and delivering bisantrene formulations | |
EP3929191A4 (en) | Method for preparing voriconazole and intermediate thereof | |
EP3241824A4 (en) | Trifluoroacethydrazide compound as well as preparation method therefor and application thereof in preparing medicament | |
KR101999278B9 (en) | Licorice Cultivation Container and Method for Cultivating Licorice | |
EP3730620A4 (en) | Cross-immunizing antigen vaccine and method for preparation thereof | |
EP3677253A4 (en) | Solid preparation comprising dutasteride and method for preparing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200213 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20210913 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12N 5/071 20100101ALI20210907BHEP Ipc: G01N 33/50 20060101ALI20210907BHEP Ipc: A01K 67/027 20060101ALI20210907BHEP Ipc: C12N 5/09 20100101AFI20210907BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20230710 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ONCOCLEW CO., LTD. |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: SG MEDICAL INC. |